References
- Maher J F, Schreiner GE. Studies on ethacrynic acid in patients with refractory edema. Ann Intem Med 1965; 62: 15–29
- Asano Y, Masuzawa H, Tabata Y. Clinical trial of bumetanide (CS-380). Basic Pharmacol Ther 1974; 2: 47–54
- Gallagher K L, Jones JK. Furosemide-induced ototoxicity. Ann Intern Med 1979; 91: 744–5
- Brown R D, Feldman AM. Pharmacology of hearing and ototoxicity. Ann Rev Pharmacol Toxicol 1978; 18: 223–52
- Rybak LP. Pathophysiology of furosemide ototoxicity. J Otolaryngol 1982; 11: 127–33
- Roberts C JC, Homeida M, Roberts F, Bogie W. Effects of piretanide, bumetanide and furosemide on electrolyte and urate excretion in normal subjects. Br J Clin Pharmacol 1978; 6: 129–33
- Teredesai P, Puschett JB. Acute effects of piretanide in normal subjects. Clin Pharmacol Ther 1979; 25: 331–9
- Morizono T, Rybak L P, Asp S. Endocochlear potential and potassium concentration in endolymph and perilymph in the chinchilla. Arch Otorhinolaryngol 1980; 229: 149–53
- Comis S D, Pratt SR. The effect of sulfamyl loop diuretics on the crossed olivocochlear bundle. Neuropharmacol 1979; 18: 739–41
- Brown R D, Manno J E, Daigneault E A, Manno BR. Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagle. Toxicol Appl Pharmacol 1979; 48: 157–69
- Brown RD. Comparative acute cochlear toxicity of intravenous bumetanide and furosemide in the purebread beagle. J Clin Pharmacol 1981; 21: 620–7
- Brummett R E, Bendrick T, Himes D. Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin. J Clin Pharmacol 1981; 628–36
- Bosher S K, Smith C, Warren RL. The effects of ethacrynic acid upon the cochlear endolymph and stria vascularis. Acta Otolaryngol (Stockh) 1973; 75: 184–91
- Brummett R, Smith C A, Ueno Y, Cameron S, Richter R. The delayed effect of ethacrynic acid on the stria vascularis of the guinea pig. Acta Otolaryngol (Stockh) 1977; 83: 98–112
- Quick C A, Hoppe W. Permanent deafness associated with furosemide administration. Ann Otol 1975; 84: 94–101
- Forge A. Observations on the stria vascularis of the guinea pig cochlea and the changes resulting from the administration of the diuretic furosemide. Clin Otolaryngol 1976; 1: 211–9
- Pike D, Bosher SK. The time course of the strial changes produced by intravenous furosemide. Hear Res 1980; 3: 79–89
- Santi P A, Duvall AJ. Morphological alterations of the stria vascularis after administration of the diuretic bumetanide. Acta Otolaryngol (Stockh) 1979; 88: 1–12
- Rarey K E, Ross MD. A survey of the effects of loop diuretics on the zonulae occludentes of the perilymph-endolymph barrier by freeze fracture. Acta Otolaryngol (Stockh) 1982; 94: 307–16
- Rybak L P, Morizono T. Effect of furosemide upon endolymph potassium concentration. Hear Res 1982; 7: 223–31
- Tasaki I, Spyropoulos CJ. Stria vascularis as source of endocochlear potential. J Neurophysiol 1959; 22: 149–55
- Kusakari J, Ise I, Comegys T V, Thalmann I, Thalmann R. Effect of ethacrynic acid, furosemide and ouabain upon the endolymphatic potential and upon high energy phosphates in the stria vascularis. Laryngoscope 1978; 88: 12–37
- Marks S C, Sohacht J. Effects of diuretics on adenylate cyclase in the inner ear. Scand Audiol 1981; 131–137, Suppl 14
- Thalmann I, Kobayashi T, Thalmann R. Arguments against a mediating role of the adenylate cyclase cyclic amp system in the ototoxic action of loop diuretics. Laryngoscope 1982; 92: 589–93
- Bosher SK. The nature of the ototoxic actions of ethacrynic acid upon the mammalian endolymph system. I. Functional effects. Acta Otolaryngol (Stockh) 1980; 89: 407–18
- Klinke R, Gotti K H, Roesch A. Ototoxic side effects of loop diuretics: furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat. Naunyn-Schmiedebergs Arch Pharmacol 1983; 322: R98
- Brown RD. Effect of bumetanide on the positive endocochlear dc potential in the cat. Toxicol Appl Pharmacol 1976; 38: 137–44
- Lumb W V, Seegmiller J, Scott RJ. Piretanide (HOE 118) in dogs. Am J Vet Res 1982; 43: 1638–41
- Tuzel IH. Comparison of adverse reactions to bumetanide and furosemide. J Clin Pharmacol 1981; 21: 615–9